In cancer cells, KRAS mutation induces transcription of genes encoding key enzymes of anabolic glucose metabolism, including glucose transporter 1, hexokinases, phosphofructokinase 1, and lactate dehydrogenase A [7]. This evidence concerns the gene KRAS and cancer.